States Ask Congress to Intervene On Drug Prices
October 30, 2014
Medicaid chiefs from red and blue states are urging Congress to stem the cost of revolutionary new drugs for hepatitis C, cancer, and other diseases. Read More
October 30, 2014
Medicaid chiefs from red and blue states are urging Congress to stem the cost of revolutionary new drugs for hepatitis C, cancer, and other diseases. Read More
October 30, 2014
Senate Minority Leader Mitch McConnell says Republicans won’t be able to repeal Obamacare anytime soon. Read More
October 30, 2014
Although the politics of Obamacare have cooled down this year — and even with declining interest in this year's midterms — the upcoming election will have a bigger influence on the direction of health care than you may think. Read More
October 30, 2014
Businesses in five states received early access Monday to select features at ObamaCare's online health insurance marketplace for small employers. Read More
October 30, 2014
U.S. small businesses are dropping health insurance for their workers, as Obamacare lets them send employees to new marketplaces where they can often get subsidies from the government to buy coverage. Read More
October 30, 2014
For Carolyn Oatman, enrolling in Medicaid this year was "a dream come true." Read More
October 28, 2014
Less than three weeks before Covered California kicks off its second open enrollment, there are problems with the website. Read More
October 28, 2014
House Minority Leader Nancy Pelosi covered plenty of territory in her meeting with The Chronicle's Editorial Board on Monday, but one issue made her more animated than any other: state Proposition 45's threat to the landmark federal health care law she shepherded through Congress in 2010. Read More
October 28, 2014
After a year fully in place, the Affordable Care Act has largely succeeded in delivering on President Obama's main promises, an analysis by a team of reporters and data researchers shows. Read More
October 28, 2014
In the past year, new hepatitis C drugs that promise higher cure rates and fewer side effects have given hope to millions who are living with the disease. Read More